Advertisement

Valvular Heart Disease and Rheumatic Fever

Chapter
  • 742 Downloads
Part of the Contemporary Cardiology book series (CONCARD)

Abstract

Aortic stenosis is the most common valvular lesion in the United States. This lesion is common because approximately 2% of individuals are born with a bicuspid valve which is prone to stenosis, and the aging population is increasing, and calcific aortic stenosis progresses with advancing years.

Keywords

Mitral Valve Valve Replacement Aortic Stenosis Mitral Regurgitation Valvular Heart Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  1. 1.
    Alam M, Sun I. Superiority of transesophageal echocardiography in detecting ruptured mitral chordae tendineae. Am Heart J 1991;121:1819.PubMedCrossRefGoogle Scholar
  2. 2.
    American College of Cardiology /American Heart Association task force on practice guidelines: management of patients with valvular heart disease. Pocket guidelines July 2000.Google Scholar
  3. 3.
    Arora R, Kalra GS, Murty GSR, et al. Percutaneous transatrial mitral commissurotomy: immediate and intermediate results. J Am Coll Cardiol 1994;23:1327.PubMedCrossRefGoogle Scholar
  4. 4.
    Biancaniello T. Innocent murmurs. Circulation 2005;111:e20–e22.PubMedCrossRefGoogle Scholar
  5. 5.
    Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med 1991;325:783.PubMedCrossRefGoogle Scholar
  6. 6.
    Bloomfield P, Wheatley DJ, Prescott RJ, et al. Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med 1991;324:573.PubMedCrossRefGoogle Scholar
  7. 7.
    Bonow RD. Asymptomatic aortic and mitral regurgitation: how should I follow the patient in practice. ACC current journal review. March/April 2001, pp. 36–41.Google Scholar
  8. 8.
    Borer JS, Bonow RO. Contemporary Approach to Aortic and Mitral Regurgitation. Circulation. 2003;108:2432.PubMedCrossRefGoogle Scholar
  9. 9.
    Braunwald E. On the natural history of severe aortic stenosis. J Am Coll Cardiol 1990;15:1018.PubMedGoogle Scholar
  10. 10.
    Cannegieter SC, Rosendaal FR, Wintzen AR, et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995;333:11.PubMedCrossRefGoogle Scholar
  11. 11.
    Carrabello BA. aortic stenosis New Engl J Med 2002;346:677–682.CrossRefGoogle Scholar
  12. 12.
    Chen Chuan-rong, Cheng TO, for the Multicenter Study Group Gaungshou, China and Washington D.C. Percutaneous balloon mitral valvuloplasty by the Inoue technique: a multicenter study of 4,832 patients in China. Am Heart J 1995;129:1197.PubMedCrossRefGoogle Scholar
  13. 13.
    Chen CR, Hu SW, Chen JY, et al. Percutaneous mitral valvuloplasty with a single rubber-nylon balloon (Inoue balloon): long-term results in 71 patients. Am Heart J 1990;120:561.PubMedCrossRefGoogle Scholar
  14. 14.
    Dajani AS, Ayoub E, Bierman FZ, et al. Guidelines for the diagnosis of rheumatic fever: Jones criteria, updated 1992. Circulation 1993;87:302.Google Scholar
  15. 15.
    Deviri E, Sareli P, Wisenbaugh T, et al. Obstruction of mechanical heart valve prostheses: clinical aspects and surgical management. J Am Coll Cardiol 1991;17:646.PubMedGoogle Scholar
  16. 16.
    Enriquez-Sarano M, Tajik AJ. Aortic regurgitation. N Engl J Med 2004;351:1539–1546.PubMedCrossRefGoogle Scholar
  17. 17.
    Eslami M, Rahimtoola SH. Decision to perform concomitant aortic valve replacement in patients undergoing coronary bypass surgery: current thinking. J Am Coll Cardiol; ACC current journal review. November/December 2001, pp. 84–87.Google Scholar
  18. 18.
    Hammermeister KE, Sethi GK, Oprian C, et al. Comparison of outcome an average of 10 years after valve replacement with a mechanical versus a bioprosthetic valve results of the V A randomized trial. J Am Coll Cardiol 1991;17:41A.Google Scholar
  19. 19.
    Hammermeister KE, Sethi GK, Oprian C, et al. Comparison of occurrence of bleeding, systemic embolism, endocarditis, valve thrombosis and reoperation between patients randomized between a mechanical prosthesis and a bioprosthesis. Results from the VA randomized trial. J Am Coll Cardiol 1991;17:362A.Google Scholar
  20. 20.
    Hancock EW. When is the best time to operate for aortic regurgitation? Cardiol Rev 1993;1:301.CrossRefGoogle Scholar
  21. 21.
    Hazen MS, Marwick TH, Underwood DA. Diagnostic accuracy of the resting electrocardiogram in detection and estimation of left atrial enlargement: an echocardiographic correlation in 551 patients. Am Heart J 1991;122:823.PubMedCrossRefGoogle Scholar
  22. 22.
    Hirata K, Triposkiadis F, Sparks, et al. The Marfan syndrome. Cardiovascular physical findings and diagnostic correlates. Am Heart J 1992;123:743.PubMedCrossRefGoogle Scholar
  23. 23.
    Iung B, Cormier B, Ducimetiere P, et al. Functional results 5 years after successful percutaneous mitral commissurotomy in a series of 528 patients and analysis of predictive factors. J Am Coll Cardiol 1996;27:407.PubMedCrossRefGoogle Scholar
  24. 24.
    Kawanishi DT, Rahimtoola SH. Catheter balloon commissurotomy for mitral stenosis: complications and results. J Am Coll Cardiol 1992;19:191.Google Scholar
  25. 25.
    Klues HG, Statler LS, Wallace RB, et al. Massive calcification of a porcine bioprosthesis in the aortic valve position and the role of calcium supplements. Am Heart J 1991;121:1829.PubMedCrossRefGoogle Scholar
  26. 26.
    Lawrence H. Conn: aortic valve prosthesis. Cardiol Rev 1994;2:219.Google Scholar
  27. 27.
    Lin S-L, et al. Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy. J Am Coll Cardiol 1994;24:1046.PubMedGoogle Scholar
  28. 28.
    Massel D, Little SH. The risks and benefits of adding antiplatelet therapy to warfarin among patients with prosthetic heart valves: a meta-analysis. J Am Coll Cardiol 2001;37:569–578.PubMedCrossRefGoogle Scholar
  29. 29.
    NHLBI Balloon Valvuloplasty Registry. Complications and mortality of percutaneous balloon mitral commissurotomy. Circulation 1992;85:2014.Google Scholar
  30. 30.
    NHLBI Balloon Valvuloplasty Registry Participants. Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI balloon valvuloplasty registry. Circulation 1991;84:2383.Google Scholar
  31. 31.
    Novaro GM, Tiong IY, Pearce GL, et al. effect of hydroxymethylglutaryl coenzyme A reductase inhibitors and progression of calcific aortic stenosis. Circulation 2001;104:2205–2209.PubMedCrossRefGoogle Scholar
  32. 32.
    Otto CM. Evaluation and management of chronic mitral regurgitation. N Engl J Med 2001;345:740–744.PubMedCrossRefGoogle Scholar
  33. 33.
    Patel JJ, Shama D, Mitha AB, et al. Balloon Valvuloplasty versus closed commissurotomy for pliable mitral stenosis: A prospective hemodynamic study. J Am Coll Cardiol 1991;18:1318.PubMedGoogle Scholar
  34. 34.
    Pellikka PA, Nishimura RA, Bailey KR, et al. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol 1990;15:1021.Google Scholar
  35. 35.
    Pollick C. What do echocardiographic reports of valvular regurgitation mean? Cardiol Rev 1994;2:324.CrossRefGoogle Scholar
  36. 36.
    Rahimtoola SH. Vasodilator therapy in chronic severe aortic regurgitation. J Am Coll Cardiol 1990;16:430.PubMedGoogle Scholar
  37. 37.
    Rahimtoola SH. The year in valvular heart disease. J Am Coll Cardiol 2005;45:111–122.PubMedCrossRefGoogle Scholar
  38. 38.
    Scognamiglio R, Rahimtoola SH, Fasoli G, et al. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal LV function. N Engl J Med 1994;331:689PubMedCrossRefGoogle Scholar
  39. 39.
    Sundt TM, current options for replacing the aortic valve in adults. J Am Coll Cardiol; ACC current journal review January February 2002, pp. 78–84.Google Scholar
  40. 40.
    The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429.CrossRefGoogle Scholar
  41. 41.
    Turpie AGG, Gent M, Laupagis A, et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 1993;329:524.PubMedCrossRefGoogle Scholar
  42. 42.
    Tuzcu EM, Block PC, Palacios IF. Comparison of early versus late experience with percutaneous mitral balloon Valvuloplasty. J Am Coll Cardiol 1991;17:1121.PubMedGoogle Scholar
  43. 43.
    Tuzcu EM, Block PC, Griffin BP, et al. Immediate and long-term outcome of percutaneousmitral valvotomy in patients 65 years and older. Circulation 1992;85:963.PubMedGoogle Scholar
  44. 44.
    Tuzcu EM, Block PC, Griffin B, et al. Percutaneous mitral balloon valvotomy in patients with calcific mitral stenosis: immediate and long-term outcome. J Am Coll Cardiol 1994;23:1604.PubMedGoogle Scholar
  45. 45.
    Wisenbaugh T, Skudicky D, Sareli P. Prediction of outcome after valve replacement for rheumatic mitral regurgitation in the era of chordal preservation. Circulation 1994;89:191.PubMedGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2005

Personalised recommendations